A novel immunotherapy strategy that generates transient engineered chimeric antigen receptor (CAR) T cells in vivo can reduce fibrosis and restore cardiac function in a mouse model of heart failure, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback